Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMV390048 in healthy volunteers
NCT02230579Phase 1Completed
- Sponsor
- Medicines for Malaria Venture
- Start
- May 2014
- Primary completion
- Feb 2015
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of MMV390048 in malaria, sponsored by Medicines for Malaria Venture. Started May 2014; status: completed.
02
Drugs
MMV390048
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02230579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02230579.